Tyler Seibert, MD, PhD, discusses cribriform and intraductal carcinoma and their implications for risk stratification and treatment selection in prostate cancer.
Tyler Seibert, MD, PhD
Advertisement
Articles by Tyler Seibert, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC
3
App-based intervention aims to increase PSA screening among Black men
4
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhD
5